Leukaemia Foundation

Leukaemia, Lymphoma, Myeloma & Related Blood Disorders.

Change Your Location:

2011 Grant Recipients

PhD Scholarships

2011 -2013

Area of Research

Per Annum

Ms N. Anstee
Walter and Eliza Hall Institute, VIC

Genetic changes promoting AML and its resistance to therapy (AML) | more

$40,000

Ms N. Christie
Centre for Cancer Biology, SA

The role of the interleukin- 3 receptor on AML stem cells (AML) | more

$40,000

Ms J. Devlin
Peter MacCallum Cancer Centre, VIC

Inhibiting cell signalling decreases ribosome synthesis and kills lymphoma cells (LYMPHOMA) | more

$40,000

Mr M. Lefebure
Peter MacCallum Cancer Centre, VIC

Investigating combinations of drugs for the treatment of an incurable blood cancer (ALL BLOOD CANCERS) | more

$40,000

Ms H. Lim 
St Vincent’s Institute, VIC 

Roles of the bone and blood vessels in the development of blood disease (ALL BLOOD CANCERS) | more

$40,000

PhD (Clinical) Scholarships
2011 - 2013

   

Dr A. Guirguis
Monash University, VIC

Targeting mechanisms of early cell death in myelodysplasia  | more

$55,000

Dr T. Teh   The Alfred Hospital, VIC

The role of a new potential therapeutic target that promotes survival of leukaemia cells | more

$55,000

Post-Doctoral Fellowships
2011 - 2013

(Funding partnership with Cure Cancer Australia Foundation)

 

Dr S. Lane
Queensland Institute of Medical Research

Treatment of blood diseases by targeting the disease-causing stem cells (ALL BLOOD CANCERS) | more

$100,000

Dr A. Ng   
Walter and Eliza Hall Institute, VIC

Identification of genetic interactions predisposing to leukaemia (LEUKAEMIA) | more

$100,000

Dr F. Tzelepis
University of Newcastle, NSW

Blood cancer patients' perceptions about the quality of care they receive (PSYCHOSOCIAL) | more

$94,723

Clinical Trial Grant
2011 - 2013

   

Dr A. Wei and Prof A. Spencer 
The Alfred Hospital, VIC

Investigating the role of targeted therapy with the FLT3 inhibitor for AML patients with FLT3 mutations (AML) | more

$198,000

Research Grants-in-Aid
2011

   

Ass Prof R. Lock et al.
Children’s Cancer Institute Australia, NSW

Improving treatment options for relapsed T-cell acute lymphoblastic) leukaemia (ALL) | more

$99,375

Dr M. McCormack & Dr C. Slape  
Walter and Eliza Hall Institute, VIC

Targeting stem cells that cause T-cell leukaemia (LEUKAEMIA) | more

$100,000

Assoc Prof D. White & Prof T. Hughes
Centre for Cancer Biology, SA  

Which kinase inhibitor is best for which CP-CML patient (CML) | more

$99,254

Dr M. Guthridge   
Australian Centre for Blood Diseases, VIC  

New approaches to targeting the survival of AML cells (AML) | more

$99,736

Associate Professor Richard D'Andrea
The University of Adelaide, SA

Dequalinium Chloride as a targeted therapy for Acute Myeloid Leukaemia (ALL) |

$100,000

Dr J. Dickinson et al.
Menzies Research Institute, TAS

Finding causative genes for blood cancers (ALL BLOOD CANCERS) | more

 $91,000

Dr S. Ting & Dr S. Russell
Peter MacCallum Cancer, VIC

Understanding how blood and leukaemia stem cells function (ALL BLOOD CANCERS) | more

 $100,000

Dr R. Tothill et al.
Peter MacCallum Cancer Centre, VIC

Defining the role of phosphoinositides in acute leukaemia (LEUKAEMIA) | more

 $100,000

Dr A. Wei & Prof C. Mitchell 
Monash University/Alfred Hospital, VIC

Defining the role of phosphoinositides in acute leukaemia (LEUKAEMIA) | more

 $100,000

Ass Prof N. Waterhouse
Mater Medical Research Institute, QLD

How cells of the body’s immune system kill blood related malignancies (ALL BLOOD CANCERS) | more

 $90,000

Prof G. Hill et al.
Queensland Institute for Medical Research, QLD

Immune competence following bone marrow transplantation | more

 $99,500

Dr P. Mollee et al.
Princess Alexandra Hospital, QLD

A clinical trial to improve the treatment of AL Amyloidosis | more

 $100,500

Ass Prof D. Curtis & Prof S. Jane
Bone Marrow Research Laboratories, VIC

Helping blood cell numbers recover after transplantation or chemotherapy | more

 $95,239

Prof D. Gottlieb
Westmead Millennium Institute, NSW

A way of using a patient’s own immune system to stop severe infections caused by potent treatment given to patients with CLL (CLL) | more

$100,000

Dr S. Grist & Ass Prof B. Kuss
Flinders Medical Centre, SA

Improving prognostic analysis of CLL through assessment of DNA repair: Y-H2A.X assay (CLL) | more

$100,000

Prof R. Christopherson & Ass Prof S. Mulligan
University of Sydney/Kolling Institute, NSW

Predicting risk and treatment response from patterns of surface markers on CLL (CLL) | more

$75,000

Dr S. Grist & Ass Prof B. Kuss
Flinders Medical Centre, SA 

Identifying patients at high risk of relapse in chronic lymphocytic leukaemia (CLL) | more

 $25,000

Honours Scholarship
2011

   

 Ms T.Nababan (di Giacomo Scholarship)

Western Australian Institute for Medical Research, WA

How MLF1 affects blood stem cells  | more

$10,000

Career Establishment Grant
2011 - 2013

   

Dr Christina Brown 
Royal Prince Alfred Hospital, NSW

The role of microRNAs in Acute Promyelocytic Leukaemia

$50,000

 

Cancer Australia PdCCRS Funding Partnership
2011-2013

   

Prof A. Lopez
Centre for Cancer Biology, SA

The role of CD123 in MDS and AML

$191,666

?